Akèy › Nefwòz lipoyid › Florid
Etid klinik pou Nefwòz lipoyid nan Florid
4 etid pou Nefwòz lipoyid ap chèche patisipan nan sit nan Florid.
Tèks ofisyèl etid la (Anglè)
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- University Of South Florida - Parent- Site Number : 8400025, Tampa
Ap rekriteFaz 2
Laj 16 a 75 · Tout sèks · Mizajou Sep 23, 2026 · NCT06500702Study of WAL0921 in Patients With Glomerular Kidney Diseases
- D & H Tamarac Research Center, Tamarac
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Aug 3, 2026 · NCT06466135Nephrotic Syndrome Study Network
- University of Miami Miller School of Medicine, Miami
Ap rekriteEtid obsèvasyon
Jiska laj 80 · Tout sèks · Mizajou Jun 10, 2026 · NCT01209000Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- University of Miami, Leonard M. Miller School of Medicine, Miami
- Nicklaus Children's Hospital, Miami
Ap rekriteFaz 2
Laj 1 a 17 · Tout sèks · Mizajou May 12, 2026 · NCT05003986Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.